COVID-19 in pediatric population
https://doi.org/10.36604/1998-5029-2021-80-100-114
Abstract
Introduction. The global spread of SARS-CoV-2 coronavirus infection worldwide determines the need to study the clinical features, complications, extrapulmonary manifestations and long-term consequences of the infection in children. While many studies have been described in adult patients, there are limited data analyzing the clinical course of the disease in pediatric patients infected with SARS-CoV-2. Aim. Review of the literature containing currently reported cases of SARS-CoV-2 infection in children to present the state of the art, understand the direction of research and unresolved issues. Materials and methods. An analysis of publications containing data from studies of SARS-CoV-2 cases in children was carried out. Results. Researchers from different countries agree that children are less susceptible to COVID19. This can create a dangerous situation, which can lead to a weakening of attention to children. Although their clinical manifestations are mainly mild to moderate symptoms, nevertheless, severe cases of the disease occur in children, which can lead to death. Conclusion. The complexity and variability of COVID-19 manifestations support the hypothesis that further research is needed on the long-term and chronic symptoms of COVID-19 in children. Failure to understand the underlying biological mechanisms behind these persistent symptoms increases missed opportunities to identify patients at risk of chronicity in order to prevent such conditions and seek rehabilitation approaches for children with COVID-19.
About the Authors
G. P. Evseeva
Khabarovsk Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Maternity and Childhood Protection
Russian Federation
Russian Federation
MD, PhD, DSc (Med.), Deputy Director on Scientific Work, Main Staff Scientist of the Group of Health and Environmental Problems of Mother and Child Health,
49/1 Voronezhskaya Str., Khabarovsk, 680022
R. S. Telepneva
Khabarovsk Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Maternity and Childhood Protection
Russian Federation
Russian Federation
Postgraduate student,
49/1 Voronezhskaya Str., Khabarovsk, 680022
E. V. Knizhnikova
Khabarovsk Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Maternity and Childhood Protection
Russian Federation
Russian Federation
Staff Scientist of Molecular Genetic Diagnostics Group,
49/1 Voronezhskaya Str., Khabarovsk, 680022
S. V. Suprun
Khabarovsk Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Maternity and Childhood Protection
Russian Federation
Russian Federation
MD, PhD, DSc (Med.), Main Staff Scientist of the Group of Health and Environmental Problems of Mother and Child Health,
49/1 Voronezhskaya Str., Khabarovsk, 680022
S. V. Pichugina
Khabarovsk Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Maternity and Childhood Protection
Russian Federation
Russian Federation
MD, PhD (Med.), Pulmonologist, Staff Scientist the Group of Clinical Immunology and Endocrinology,
49/1 Voronezhskaya Str., Khabarovsk, 680022
E. I. Yakovlev
Khabarovsk Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Maternity and Childhood Protection
Russian Federation
Russian Federation
Junior Staff Scientist of the Group of Health and Environmental Problems of Mother and Child Health,
49/1 Voronezhskaya Str., Khabarovsk, 680022
O. I. Galyant
Khabarovsk Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Maternity and Childhood Protection
Russian Federation
Russian Federation
MD, PhD, Senior Staff Scientist of the Group of Clinical Immunology and Endocrinology, Chief Medical Officer,
49/1 Voronezhskaya Str., Khabarovsk, 680022
V. K. Kozlov
Khabarovsk Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Maternity and Childhood Protection
Russian Federation
Russian Federation
MD, PhD, DSc (Med.), Professor, Corresponding Member of RAS, Main Staff Scientist of the Group of Health and Environmental Problems of Mother and Child Health,
49/1 Voronezhskaya Str., Khabarovsk, 680022
O. A. Lebed’ko
Khabarovsk Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Maternity and Childhood Protection
Russian Federation
Russian Federation
MD, PhD, DSc (Med.), Director of the Khabarovsk Branch,
49/1 Voronezhskaya Str., Khabarovsk, 680022
References
1. Zhou P., Yang X., Wang X., Hu B., Zhang L., Zhang W., Si H., Zhu Y., Li B., Huang C., Chen H., Chen J., Luo Y., Guo H., Jiang R., Liu M., Chen Y., Shen X., Wang X., Zheng X., Zhao K., Chen Q., Deng F., Liu L., Yan B., Zhan F., Wang Y., Xiao G., Shi Z. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579(7798):270–273. https://doi.org/10.1038/s41586-020-2012-7
2. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., Xie X., Yin W., Li H., Liu M., Xiao Y., Gao H., Guo L., Xie J., Wang G., Jiang R., Gao Z., Jin Q., Wang J., Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395:497–506. https://doi:10.1016/S0140-6736(20)30183-5
3. Bhattacharjee B., Ikbal A.M.A., Sahu R.K., Ratra M. Insight into Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): Rationalized Review Special Reference to COVID-19. Pharmaceutical and Biosciences Journal 2021; 9(1):01–08. https://doi:10.20510/ukjpb/9/i1/1609692170
4. Rajabian M., Doagooyan M., Coronavirus Disease 2019 (Covid-19) in Middle East: Data, Facts and Doubts. Int. J. Pediatr. 2020; 8(6):11429–11434. https://doi:10.22038/ijp.2020.48778.3914
5. Rodriguez-Morales A., Bonilla-Aldana D.K., Tiwari R., Sah R., Rabaan A.A., Dhama K. COVID-19, an Emerging Coronavirus Infection: Current Scenario and Recent Developments-An Overview. Journal of Pure and Applied Microbiology. 2020; 14(1):6150. https://doi:10.22207/JPAM.14.1.02
6. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323:1239–1242. https://doi:10.1001/jama.2020.2648
7. Dong Y., Mo X., Hu Y., Qi X., Jiang F., Jiang Z., Tong S.. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics 2020; 145(6):e20200702. https://doi:10.1542/peds.2020-0702
8. Bialek S., Gierke R., Hughes M., McNamara L.A., Pilishvili T., Skoff T. Coronavirus Disease 2019 in ChildrenUnited States, February 12–April 2, 2020. Morbidity and Mortality Weekly Report 2020; 69(14):422–26. https://doi:10.15585/mmwr.mm6914e4
9. Goldman R.D. Coronavirus disease 2019 in children: Surprising findings in the midst of a global pandemic. Can. Fam. Physician 2020; 66(5):332–334.
10. Chen Y., Peng H., Wang L., Zhao Y., Zeng L., Gao H., Liu Y. Infants born to mothers with a new coronavirus (COVID-19). Front. Pediatr. 2020; 8:104. https://doi:10.3389/fped.2020.00104
11. Alexandrovich Yu. S., Alekseeva E.I., Bakradze M.D., Baranov A.A., Batysheva T.T., Vashakmadze N.D., Vershinina M.G., Vishneva E.A., Glazyrina A.A., Gordeeva O.B., Dyakonova E.Yu., Zholobova E.S., Zabolotsky D.V., Zvereva N.N., Zelenkova I.V., Ivanov D.O., Kaytukova E.V., Karkashadze G.A., Konovalov I.V., Kruchko D.S., Kulichenko T.V., Kurbanova S.Kh., Levina Yu.G., Lobzin Yu.V., Mazankova L.N., Margieva T.V., Namazova-Baranova L.S., Novikova Yu.Yu., Ovsyannikov D.Yu., Petryaykina E.E., Petrenko Yu.V., Petrova N.V., Prometnoy D.V., Pshenisov K.V., Revunenkov G.V., Rtishchev A.Yu., Rusinova D.S., Sayfullin M.A., Sayfullin R.F., Selimzyanova L.R., Tatochenko V.K., Tepaev R.F., Uskov A.N., Fedoseenko M.V., Fisenko A.P., Khar’kin A.V., Efendieva K.E., Yakovlev A.V. Clinical Features and Management of the Disease Caused by New Coronaviral Infection (COVID-19) in Children. Version 2. Pediatricheskaya farmakologiya = Pediatric pharmacology. 2020; 17(3):187–212 (in Russian). https://doi:10.15690/pf.v17i3.2123
12. Lu X., Zhang L., Du H., Zhang J., Li Y.Y., Qu J., Zhang W., Wang Y., Bao S., Li Y., Wu C., Liu H., Liu D., Shao J., Peng X., Yang Y., Liu Z., Xiang Y., Zhang F., Silva R.M., Pinkerton K.E., Shen K., Xiao H., Xu S., Wong G.W.K. SARS-CoV-2 Infection in Children. N. Engl. J. Med. 2020; 382(17):1663–1665. https://doi:10.1056/NEJMc2005073
13. Cai J., Xu J., Lin D., Zhi Y., Lei X., Zhenghai Q., Yuehua Z., Hua Z., Ran J., Pengcheng L., Xiangshi W., Yanling G., Aimei X., He T., Hailing C., Chuning W., Jingjing L, Jianshe W., Mei1 Z. A Case Series of Children With 2019 Novel Coronavirus Infection: Clinical and Epidemiological Features. Clin. Infect. Dis. 2020; 71(6):1547–1551. https://doi:10.1093/cid/ciaa198 14. Brodin Р. Immune determinants of COVID-19 disease presentation and severity. Nature Medicine 2021; 27:28– 33. https://doi.org/10.1038/s41591-020-01202-8
14. Diorio C., McNerney K. O., Lambert M., Paessler M., Anderson E.M., Henrickson S.E., Chase J., Liebling E.J., Burudpakdee C., Lee J.H., Balamuth F.B., Blatz A.M., Chiotos K., Fitzgerald J.C., Giglia T.M., Gollomp K., John A.R.O., Jasen C., Leng T., Petrosa W., Vella L.A., Witmer C., Sullivan K.E., Laskin B.L., Hensley S.E., Bassiri H., Behrens E.M., Teachey D.T. Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations. Blood Advances 2020; 23(4):6051–6063. https://doi:10.1182/bloodadvances.2020003471
15. Chan J.F., Yuan S., Kok K.H., To K.K., Chu H., Yang J., Xing F., Liu J., Yip C.C., Poon R.W., Tsoi H., Lo S.K., Chan K., Poon V.K., W. Chan, Ip J.D., Cai J., Cheng V.C., Chen H., Hui C.K, Yuen K.Y. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020; 395(10223):514–523. https://doi:10.1016/S0140-6736(20)30154-9
16. Tagarro A., Epalza C., Santos M., Sanz-Santaeufemia F.J., Otheo E., Moraleda C., Calvo C. Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, Spain. JAMA Pediatr. 2020; 174(10):1009. https://doi:10.1001/jamapediatrics.2020.1528
17. Chang D., Mo G., Yuan X., Tao Y., Peng X., Wang F., Xie L., Sharma L., Dela Cruz C.S., Qin E. Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection. Am. J. Respir. Crit. Care Med. 2020; 201(9):1150–1152. https://doi: 10.1164/rccm.202003-0524LE
18. Kam K.Q., Yung C.F., Cui L., Lin T.P.R., Mak T.M., Maiwald M., Li J., Chong C.Y., Nadua K., Tan N.W.H., Thoon K.C. A Well Infant With Coronavirus Disease 2019 With High Viral Load. Clin. Infect. Dis. 2020; 71:847–849. https://doi: 10.1093/cid/ciaa201
19. Hoang A., Chorath K., Moreira A., Evans M., Burmeister-Morton F., Burmeister F., Naqvi R., Petershack M., Moreira A. COVID-19 in 7780 pediatric patients: a systematic review. EClinicalMedicine 2020; 24:100433. https://doi.org/10.1016/j.eclinm.2020.100433
20. Bailey L.C., Razzaghi H., Burrows E.K., Bunnell T., Camacho P.E.F., Christakis D.A., Eckrich D., Kitzmiller M., Lin S.M., Magnusen B.C., Newland J., Pajor N.M., Ranade D., Rao S., Sofela O., Zahner J., Bruno C., Forrest C.B. Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States. JAMA Pediatr. 2021; 75(2):176–184. https://doi:10.1001/jamapediatrics.2020.5052
21. Wang D., Hu B., Hu C. Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., Zhao Y., Li Y., Wang X., Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus Infected Pneumonia in Wuhan, China. JAMA 2020; 323(11):1061–1069. https://doi:10.1001/jama.2020.1585
22. Diorio C., Henrickson S.E., Vella L.A., McNerney K.O., Chase J., Burudpakdee C., Lee J. H., Jasen C., Balamuth F.B., Barrett D.M., Banwell B.L., Bernt K.M., Blatz A.M., Chiotos K., Fisher B.T., Fitzgerald J.C., Gerber J.S., Gollomp K., Gray C., Grupp S.A., Harris R.M., Kilbaugh T.J., John A.R.O., Lambert M., Liebling E.J., Paessler M.E., Petrosa W., Phillips C., Reilly A.F., Romberg N.D., Seif A., Sesok-Pizzini D.A, Sullivan K.E., Vardaro J., Behrens E.M., Teachey D.T., Bassiri H. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV2. J. Clin. Invest. 2020; 130(11):5967–5975. https://doi: 10.1172/jci140970
23. Riphagen S., Gomez X., Gonzalez-Martinez C., Wilkinson N., Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 2020; 395(10237):1607–1608. https://doi:10.1016/S0140-6736(20)31094-1
24. Caro-Paton G.L., de Azagra-Garde A. M., García-Salido A., Cabrero-Hernandez M., Tamariz A., Nieto-Moro M. Shock and Myocardial Injury in Children With Multisystem Inflammatory Syndrome Associated With SARS-CoV-2 Infection: What We Know. Case Series and Review of the Literature. J. Intensive Care Med. 2021; 36(4):392–403. https://doi.org/10.1177/0885066620969350
25. Lee P.Y., Day-Lewis M., Henderson L.A., Friedman K.G., Lo J., Roberts J.E., Lo M.S., Platt C.D., Chou J., Hoyt K.J., Baker A.L., Banzon T.M., Chang M.H., Cohen E., de Ferranti S.D., Dionne A., Habiballah S., Halyabar O., Hausmann J.S., Hazen M.M., Janssen E., Meidan E., Nelson R.W., Nguyen A.A., Sundel R.P., Dedeoglu F., Nigrovic P.A., Newburger J.W., Son M.B.F. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. J. Clin. Invest. 2020; 130(11):5942–5950. https://doi:10.1172/JCI141113
26. Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R., Manson J.J. СOVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020; 395(10229):1033–1034. https://doi:10.1016/S0140-6736(20)30628-0
27. Malakhov A.B., Gutyrchik T.A., Samitova E.R., Dronov I.A., Osmanov I.M., Mazankova L.N., Nedostoev A.A., Antsupova M.A., Kolosovaet N.G. Novel coronavirus infection in childhood: literature review and clinical observation. Pediatrics. Consilium Medicum. 2020; 4:31–37 (in Russian). https://doi:10.26442/26586630.2020.4.200560
28. Cheong R.C.T., Jephson C., Frauenfelder C., Cavalli L., Moshal K., Butler C.R., Wyatt M.E. Otolaryngologic Manifestations in Pediatric Inflammatory Multisystem Syndrome Temporally Associated With COVID-19. JAMA Otolaryngol Head Neck Surg. 2021; e205698. https://doi:10.1001/jamaoto.2020.5698
29. Gentile F., Aimo A., Forfori F., Catapano G., Clemente A., Cademartiri F., Emdin M., Giannoni A. COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead. Eur. J. Prev. Cardiol. 2020; 27:1442–1446. https://doi.org/10.1177/2047487320932695
30. Spagnolo P., Balestro E., Aliberti S., Cocconcelli E., Biondini D., Casa G.D., Sverzellati N., Maher T.M. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Resp. Med. 2020; 8(8):750–752. https://doi:10.1016/S2213-2600(20)30225-3
31. Huang W., Wu Q., Chen Z. Xiong Z., Wang K., Tian J., Zhang S. The potential indicators for pulmonary fibrosis in survivors of severe COVID-19. Journal of Infection 2021; 82(2):e5–e7. https://doi.org/ 10.1016/j.jinf.2020.09.027 0163- 4453
32. Li Y., Wu J., Wang S., Li X., Zhou J., Huang B., Luo D., Cao Q., Chen Y., Chen S., Ma L., Peng L., Pan H., Travis W.D., Nie X. Progression to fibrosing diffuse alveolar damage in a series of 30 minimally invasive autopsies with COVID19 pneumonia in Wuhan, China. Histopathology 2021; 78:542–555. https://doi.org/10.1111/his.14249
33. Naicker S., Yang C., Hwang S., Liu B., Chen J., Jha V. The novel coronavirus 2019 epidemic and kidneys. Kidney Int. 2020; 97(5):824–828. https://doi: 10.1016/j.kint.2020.03.001
34. Gross O., Moerer O., Weber M., Huber T.B, Scheithauer S. COVID-19-associated nephritis: early warning for disease severity and complications? Lancet 2020; 395(10236): e87–e88. https://doi.org/10.1016/S0140-6736(20)31041-2
35. Enya T., Morimoto Y., Oshima R., Miyazaki K., Miyazawa T., Okada M., Sugimoto K. Nephrotic syndrome relapse in a boy with COVID-19. CEN Case Rep. 2021; 1–4. https://doi:10.1007/s13730-021-00587-w
36. Noris M., Benigni A., Remuzzi G. The case of complement activation in COVID-19 multiorgan impact. Kidney Int. 2020; 98(2):314–322. https://doi:10.1016/j.kint.2020.05.013
37. Puelles V.G, Lütgehetmann M., Lindenmeyer M.T., Sperhake J.P., Wong M.N., Allweiss L., Chilla S., Heinemann A., Wanner N., Liu S., Braun F., Lu S., Pfefferle S., Schröder A.S., Edler C., Gross O., Glatzel M., Wichmann D., Wiech T., Kluge S., Pueschel K., Aepfelbacher M., Huber T.B. Multiorgan and Renal Tropism of SARS-CoV-2. N. Engl. J. Med. 2020; 383(6):590–592. https://doi: 10.1056/NEJMc2011400
38. Su H., Yang M., Wan C., Yi L., Tang F., Zhu H., Yi F., Yang H., Fogo A.B., Nie X., Zhang C. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020; 98(1):219-227. https://doi.org/10.1016/j.kint.2020.04.003
39. Ferrari R., Pasquale G.D., Rapezzi C. Commentary: What is the relationship between Covid-19 and cardiovascular disease? Int. J. Cardiol. 2020; 310:167–168. https://doi:10.1016/j.ijcard.2020.03.074
40. Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J., Shchendrygina A., Escher F., VasaNicotera M., Zeiher A.M., Vehreschild M., Nagel E. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(11):1265–1273. https://doi:10.1001/jamacardio.2020.3557
41. Xiao H., Wang X., Xu Y., Wang C. Research advances in cardiovascular system damage caused by SARS-CoV-2 in children. Zhongguo Dang Dai Er Ke Za Zhi 2020; 22(4):299–304. https://doi:10.7499/j.issn.1008-8830.2003086
42. Desouky E. SARS-CoV-2 tropism: what urologists need to know. African Journal of Urology. 2021; 27:23. https://doi.org/10.1186/s12301-021-00126-0
43. Pan L., Mu M., Yang P., Sun Y., Wang R., Yan J., Li P., Hu B., Wang J., Hu C., Jin Y., Niu X., Ping R., Du Y., Li T., Xu G., Hu Q., Tu L. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am. J. Gastroenterol. 2020; 115(5):766–773. https://doi:10.14309/ajg.0000000000000620
44. Mao R., Qiu Y., He J., Tan J., Li X., Liang J., Shen J., Zhu L., Chen Y., Iacucci M., Ng S.C., Ghosh S., Chen M. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 2020; 5:667–678. https://doi:10.1016/S2468-1253(20)30126-6
45. Galanopoulos M., Gkeros F., Doukatas A., Karianakis G., Pontas C., Tsoukalas N., Viazis N., Liatsos C., Mantzaris. G.J. COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract. World. J. Gastroenterol. 2020; 26(31):4579–4588. https://doi:10.3748/wjg.v26.i31.4579
46. Brancatella A., Ricci D., Viola N., Sgrò D., Santini F., Latrofa F. Subacute Thyroiditis After Sars-COV-2 Infection. J. Clin. Endocrinol. Metab. 2020; 105(7):2367–2370. https://doi:10.1210/clinem/dgaa276
47. Troshina E.A., Melnichenko G.A., Senyushkina E.S., Mokrysheva N.G. Adaptation of the hypothalamo-pituitarythyroid and hypothalamo-pituitary-adrenal systems to a new infectious disease – COVID-19 in the development of COVID19 pneumonia and/or cytokine storm. Clinical and Experimental Thyroidology 2020; 16(1):21–27 (in Russian). https://doi.org/10.14341/ket12461
48. Yachou Y., El Idrissi A., Belapasov V. Benali S.A. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Neurol. Sci. 2020; 41(10):2657– 2669. https://doi.org/10.1007/s10072-020-04575-3
49. Conforti C., Dianzani C., Agozzino M., Giuffrida R., Marangi G.F., di Meo N., Morariu S.-H., Persichetti P., Segreto F., Zalaudek I., Neagu N. Cutaneous Manifestations in Confirmed COVID-19 Patients: A Systematic Review. Biology 2020; 9(12):449. https://doi.org/10.3390/biology9120449
50. Young S., Fernandez A. P. Skin manifestations of COVID-19. Cleveland Clinic Journal of Medicine 2020; https://doi:10.3949/ccjm.87a.ccc031
51. Blair P.W., Brown D.M., Jang M., Antar A.A.R., Keruly J.C., Bachu V.S., Townsend J.L., Tornheim J.A., Keller S.C., Sauer L., Thomas D.L., Manabe Y.C. The Clinical Course of COVID-19 in the Outpatient Setting: A Prospective Cohort Study. Open Forum Infect. Dis. 2021; 8(2):ofab007. https://doi:10.1093/ofid/ofab007
52. Kabi A., Mohanty A., Mohanty A.P., Kumar S. Post COVID-19 Syndrome: A Literature Review. Journal of Advances in Medicine and Medical Research 2020; 32(24):289–295. https://doi:10.9734/JAMMR/2020/v32i2430781
53. Dennis A., Wamil M., Kapur S., Alberts J., Badley A.D., Decker G. A., Rizza S.A., Banerjee R., Banerjee A. Multiorgan impairment in low-risk individuals with long COVID. medRxiv 2020; Preprint. https://doi.org/10.1101/2020.10.14.20212555
54. Goërtz Y.M.J., Van Herck M., Delbressine J.M., Vaes A.W., Meys R., Machado F.V.C., Houben-Wilke S., Burtin C., Posthuma R., Franssen F.M.E., van Loon N., Hajian B., Spies Y., Vijlbrief H., van’t Hul A. J., Janssen D. J.A., Spruit M. A. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020; 6:00542. https://doi.org/10.1183/23120541.00542-2020
55. Shah W., Hillman T., Playford E.D., Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ 2021; 372:n136. https://doi.org/10.1136/bmj.n136
56. Davanzo G.G., Codo A. C., Brunetti N. S., Boldrini V., Knittel T.L., Monterio L.B., de Moraes D., Ferrari A.J.R., de Souza G.F., Muraro S.P., Profeta G.S., Wassano N.S., Santos L.N., Carregari V.C., Dias A.H.S., Virgilio-da-Silva J.V., Castro Í., Silva-Costa L.C., Palma A., Mansour E., Ulaf R.G., Bernardes A.F., Nunes T.A., Ribeiro L.C., Agrela M.V., Moretti M.L., Buscaratti L.I., Crunfli F., Ludwig R.G., Gerhardt J.A., Seste-Costa R., Forato J., Amorin M.R., Texeira D.A.T., Parise P.L., Martini M.C., Bispo-dos-Santos K., Simeoni C.L., Granja F., Silvestrini V.C., de Oliveira E.B., Faça V.M., Carvalho M., Castelucci B.G., Pereira A.B., Coimbra L.D., Rodrigues P.B., Gomes A.B.S.P., Pereira F.B., Santos L.M.B., Sposito A.C., Carvalho R.F., Vieira A.S., Vinolo M.A.R., Damasio A., Velloso L.A., Nakaya H.I., Marques-Souza H., Marques R.E., Martins-de-Souza D., Skaf M.S., Proença-Modena J.L., Moraes-Vieira P.M., Mori M.A., Farias A.S. SARS-CoV-2 Uses CD4 to Infect T Helper Lymphocytes. medRxiv 2020; Preprint. https://doi.org/10.1101/2020.09.25.20200329
57. Ludvigsson J.F. Case report and systematic review suggest that children may experience similar long‐term effects to adults after clinical COVID‐19. Acta Paediatr. 2021; 110(3):914–921. https://doi.org/10.1111/apa
58. Green P. Risks to children and young people during covid-19 pandemic. BMJ 2020; 369:m1669. https://doi: 10.1136/bmj.m1669
59. Buonsenso D., Munblit D., De Rose C., Sinatti D., Ricchiuto A., Carfi A., Valentini P. Preliminary Evidence on Long COVID in children. medRxiv 2021; Preprint. https://doi.org/10.1101/2021.01.23.21250375
Review
For citations:
Evseeva G.P., Telepneva R.S., Knizhnikova E.V., Suprun S.V., Pichugina S.V., Yakovlev E.I., Galyant O.I., Kozlov V.K., Lebed’ko O.A. COVID-19 in pediatric population. Bulletin Physiology and Pathology of Respiration. 2021;(80):100-114. (In Russ.) https://doi.org/10.36604/1998-5029-2021-80-100-114
Views:
407
Email this article 